Trident Lifeline (TLL) Share Price Falls 8.86% as Healthcare Valuation Cools

Trident Lifeline Share Price moved lower today, with Trident Lifeline Share Price at Rs 370 after an 8.86% decline. The company’s market capitalisation stood at Rs 490.24 Cr, placing Trident Lifeline in the Micro Cap category. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the move important for readers tracking Trident Lifeline Share Price Today, Trident Lifeline Stock News and Trident Lifeline Share Price News. The key questions are straightforward: what changed in price action, how does the valuation sit against the healthcare benchmark, and what should investors monitor next through a Trident Lifeline Share Price Update?

At Rs 370, Trident Lifeline Share Price traded below the previous close of Rs 405.95. The latest Univest figures show the stock moving inside a fairly tight intraday band, which helps frame today’s decline without adding any unsupported explanation. In the sections below, Univest breaks down the price move, the fundamental profile, the healthcare sector benchmark, and peer comparison in a way that can support Trident Lifeline Stock Analysis and Trident Lifeline Fundamental Analysis.

Trident Lifeline (TLL) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 370
Previous Close	Rs 405.95
Today's Move	-Rs 35.95 (-8.86%)
Open	Rs 396
High	Rs 400
Low	Rs 368
Market Capitalisation	Rs 490.24 crore
Market Cap Category	Micro Cap

Trident Lifeline Share Price Today opened at Rs 396, touched a high of Rs 400 and a low of Rs 368 before trading at Rs 370. The day’s change was Rs -35.95, or -8.86%, versus the previous close of Rs 405.95. That means the stock was already below the previous close soon after the open, and the intraday low sat close to the day’s final traded level. Trident Lifeline Share Price therefore reflects a clear share price fall in today’s market, with the move staying within the session’s Rs 32 range between the high and the low.

For readers searching Trident Lifeline Share Price Live, Trident Lifeline Share Price Today and Trident Lifeline Share Price Update, the important point is simple: the decline is confirmed, the market cap remains Rs 490.24 Cr, and the stock is trading as a Micro Cap. Univest treats that as a price action event first, not a story about unverified cause. Trident Lifeline Share Price now needs follow-through context from fundamentals, sector valuation and peer comparison before any broader conclusion can be drawn.

Trident Lifeline (TLL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 490.24 crore
P/E Ratio	25.49x
P/B Ratio	4.93x
ROE	18.78%
ROCE	19.17%
EPS	Rs 15.92
Book Value Per Share	Rs 82.4
Dividend Yield	0%

Trident Lifeline Share Price sits alongside a reported P/E ratio of 25.49 and a P/B ratio of 4.93. The company’s ROE is 18.78% and ROCE is 19.17%, which places return metrics in a healthier zone than many broad market averages, even as the share price has fallen today. EPS stands at Rs 15.92, book value is Rs 82.4 per share, and dividend yield is 0%. Those numbers matter because EPS shows earnings attributable to each share, book value per share shows the accounting net worth behind each share, and dividend yield shows the historical payout relative to the current price.

From a valuation angle, Trident Lifeline Share Price is not trading on a low multiple in absolute terms, but the broader reading depends on the sector benchmark and peer set. The current market cap of Rs 490.24 Cr also places the company below the benchmark median market capitalisation for the same industry. On Univest, Trident Lifeline Fundamental Analysis is therefore a mix of decent return ratios and a valuation that deserves comparison rather than assumption. No profit figure is stated here because only the verified metrics are used. The next step is to place Trident Lifeline Share Price inside the healthcare and pharmaceuticals benchmark.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.49x
Benchmark Median P/E	32.43x
Benchmark Average P/E	49.46x
Benchmark P/E Range	3.4x to 699.02x
Company P/B Ratio	4.93x
Benchmark Median P/B	2.89x
Benchmark Average P/B	4.38x
Company ROE	18.78%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.68%
Company ROCE	19.17%
Benchmark Median ROCE	13.61%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 490.24 crore
Benchmark Median Market Cap	Rs 776.09 crore
Benchmark Average Market Cap	Rs 14,255.4 crore

Trident Lifeline Share Price should be read against the Healthcare sector and Pharmaceuticals & Drugs industry, where the benchmark scope covers 199 companies in the same industry. The company’s P/E of 25.49 compares with a benchmark median of 32.43 and an average of 49.46, while the benchmark range runs from 3.4 to 699.02. On that basis, Trident Lifeline Share Price is below the industry median and far below the industry average, which gives the valuation a more moderate placement than several large healthcare names. The company’s P/B of 4.93 is above the benchmark median of 2.89 and above the average of 4.38, which keeps the book value comparison in focus.

ROE of 18.78% is above the benchmark median of 11.7% and above the average of 10.68%, while ROCE of 19.17% is also above the benchmark median of 13.61% and the average of 13.4%. The sector snapshot also shows a market cap median of Rs 776.09 Cr and an average of Rs 14,255.4 Cr across the same industry, so Trident Lifeline Share Price is moving in a smaller-company context. In sector terms, the share price fall today is best treated as a market move inside a smaller-cap healthcare name rather than as a sector-wide signal. That is the cleanest reading Univest can support from the verified numbers.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,41,477.63	36.9	5.16	14.85	19.11
Divi's Laboratories	DIVISLAB	2,53,031.38	85.99	14.24	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,85,216.32	85.72	20.83	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,20,897.46	26.42	4.42	19.69	21.39
Cipla	CIPLA	1,12,205.15	33.15	3.18	11.83	16

Peer Comparison gives Trident Lifeline Share Price a useful frame. Among the listed peers, Sun Pharmaceutical Industries has a P/E of 36.9 and market cap of Rs 4,41,477.63 Cr, while Divi’s Laboratories trades at a P/E of 85.99 and market cap of Rs 2,53,031.38 Cr. Torrent Pharmaceuticals shows a P/E of 85.72 and market cap of Rs 1,85,216.32 Cr. Zydus Lifesciences has a P/E of 26.42 and market cap of Rs 1,20,897.46 Cr, close to Trident Lifeline Share Price on P/E but much larger in size.

Cipla trades at a P/E of 33.15 and market cap of Rs 1,12,205.15 Cr, while Dr. Reddy’s Laboratories shows a P/E of 32.38 and market cap of Rs 1,02,039.66 Cr. Mankind Pharma has a P/E of 51.46 and market cap of Rs 1,00,764.41 Cr, Aurobindo Pharma shows 26.39, and Lupin has a P/E of 17.04 with ROE of 27.11% and ROCE of 28.86%. Against this set, Trident Lifeline Share Price stands out as a much smaller Micro Cap with return ratios that compare well with several peers, even though its P/B of 4.93 is higher than some peers such as Cipla, Dr. Reddy’s and Aurobindo. Univest therefore views the peer picture as one of valuation comparison, not a recommendation.

Why Investors Are Watching Trident Lifeline

• Trident Lifeline Share Price fell 8.86% today, which keeps the stock in focus for active price monitoring.
• The stock traded at Rs 370 after opening at Rs 396 and touching a low of Rs 368.
• Market capitalisation of Rs 490.24 Cr places it in the Micro Cap category.
• ROE of 18.78% and ROCE of 19.17% offer operating-return context for Trident Lifeline Share Price.
• P/E of 25.49 and P/B of 4.93 invite comparison with healthcare peers and the industry benchmark.

About Trident Lifeline

Trident Lifeline operates in Healthcare and the Pharmaceuticals & Drugs industry. The verified company details available here identify the sector and industry, along with the market position implied by its Micro Cap classification and Rs 490.24 Cr market capitalisation. Trident Lifeline Share Price therefore belongs to a healthcare name that can be assessed through earnings, book value and return ratios rather than through any technical lens. Univest focuses on the verified company facts that are available: the stock market context, the valuation metrics, and the peer set within pharmaceuticals and drugs.

For investors tracking Trident Lifeline Share Price, the company’s profile is best understood through its ratios and sector placement rather than through unsupported business claims. This is the kind of Trident Lifeline Stock News that benefits from precise numbers and restrained interpretation.

Track Trident Lifeline Share Price on Univest

Use Trident Lifeline (TLL) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Trident Lifeline Share Price on Univest for live share price movement, fundamental ratios, 52-week levels and market insights in one place. Trident Lifeline Share Price Today, Trident Lifeline Stock Analysis and Trident Lifeline Fundamental Analysis are all easier to follow when price action is read beside valuation, ROE, ROCE, EPS and book value. Univest keeps the focus on verified market information.

Frequently Asked Questions

Why is Trident Lifeline Share Price falling today?

Ans. Trident Lifeline Share Price fell 8.86% to Rs 370 from the previous close of Rs 405.95. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is Trident Lifeline Share Price Today?

Ans. Trident Lifeline Share Price Today was Rs 370. The stock opened at Rs 396, touched a high of Rs 400 and a low of Rs 368 before trading near the lower end of the day’s range.

What is Trident Lifeline market capitalisation?

Ans. Trident Lifeline market capitalisation stood at Rs 490.24 Cr. That places the company in the Micro Cap category and below the same-industry market cap median of Rs 776.09 Cr. The company operates in the Healthcare sector.

What does Trident Lifeline Share Price tell investors today?

Ans. Trident Lifeline Share Price signals a clear intraday decline, but the valuation and return ratios still need to be read together. P/E is 25.49, ROE is 18.78% and ROCE is 19.17%.

Is Trident Lifeline valuation higher or lower than peers?

Ans. Trident Lifeline P/E of 25.49 is below the industry median of 32.43 and below several peers such as Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. Its P/B of 4.93 remains above the industry median.

How do Trident Lifeline ROE and ROCE compare with the industry?

Ans. Trident Lifeline ROE of 18.78% and ROCE of 19.17% are above the industry median and average in the same sector snapshot. That gives Trident Lifeline Share Price useful return context despite today’s fall.

What are Trident Lifeline EPS and book value?

Ans. Trident Lifeline EPS is Rs 15.92 and book value is Rs 82.4 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.

Should investors track Trident Lifeline Share Price on Univest?

Ans. Yes, investors tracking Trident Lifeline Share Price can use Univest to follow live price movement, valuation ratios, sector comparison and market capitalisation. That helps place the day’s fall in a wider healthcare context.